Abstract
Introduction: Anticoagulation is essential during CPB in cardiac surgery. It is generally performed using heparin; however the widely used formula for its dosing is based solely on body weight. Although the formula assumes activated clotting time (ACT) to be within normal range, baseline ACT varies in each patient. Thus, we developed an original formula, which takes into account baseline ACT in addition to body weight to calculate a more proper dose for initial administration of heparin. In this study, we monitored the ACT to examine if the dose of heparin calculated using our formula can prolong the ACT to the target range, and we determined the factors which interfere with the prolongation of ACT. Methods: Between October 2010 and April 2011, 141 consecutive patients underwent cardiac surgery requiring cardiopulmonary bypass at our hospital. We measured ACT 3 minutes after the initial administration of heparin and considered ACT values >400 seconds as appropriate for safe initiation of CPB. Results: Using the proposed formula, administered heparin dose was 241 ± 27 IU/kg and target ACT was achieved in 86.4% of patients. Multivariate analysis was performed to determine the effect of patient background factors on target ACT achievement. Body weight, age, and preoperative heparin therapy, which showed significant differences, were further analyzed. Conclusions: This study demonstrated that our newly developed formula could be used to properly calculate the optimal initial dose of heparin.
Highlights
Anticoagulation is essential during cardiopulmonary bypass (CPB) in cardiac surgery
The formula we propose takes into account body weight (BW) and the baseline activated clotting time (ACT) of each patient, while the conventional formula assumes a bACT of 100 seconds for all patients; Initial dose of heparin (IU)=BW ∗300 ∗(450 − bACT) (450 −100)
We evaluated whether heparin dose determined using our formula considering baseline ACT in addition to BW was useful and safe for patients undergoing CPB
Summary
Anticoagulation is essential during CPB in cardiac surgery It is generally performed using heparin; the widely used formula for its dosing is based solely on body weight. We developed an original formula, which takes into account baseline ACT in addition to body weight to calculate a more proper dose for initial administration of heparin. 300 IU/kg is widely used as the initial dose of heparin administered before starting CPB [2] [3] Calculation of this value is solely dependent on patient’s body weight (BW), assuming that the ACT value was within normal range. We determine which factor(s) affect heparin activity by comparing patients who reached the target ACT range after initial administration of heparin with those who did not
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call